Concepedia

Publication | Closed Access

Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.

111

Citations

22

References

2002

Year

Abstract

These data confirm that thalidomide is active in patients with advanced relapsed/refractory MM and represent the basis for ongoing clinical trials aimed at testing the role of this drug as front line therapy for newly diagnosed disease.

References

YearCitations

Page 1